Anne Tucker
Psychiatric/Mental Health · Gulfport, MSNPI 1790952950
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 289 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 35.2% of the total. Among psychiatric/mental health clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$508
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$446
- Alkermes, Inc.$402
- Lundbeck LLC$396
- Indivior Inc.$338
- plus $1K from 7 others
What the payments were for
- Food & beverage$4,91498%
- Education$912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 117 | $1,763 |
| Johnson & Johnson | 30 | $508 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 21 | $446 |
| Alkermes, Inc. | 27 | $402 |
| Lundbeck LLC | 19 | $396 |
| Indivior Inc. | 15 | $338 |
| Neurocrine Biosciences, Inc. | 16 | $312 |
| Vanda Pharmaceuticals Inc. | 10 | $265 |
| Teva Pharmaceuticals USA, Inc. | 9 | $209 |
| Otsuka America Pharmaceutical, Inc. | 9 | $142 |
| Sunovion Pharmaceuticals Inc. | 11 | $108 |
| E.r. Squibb & Sons, L.L.C. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
How this compares
$5,005 in reported general payments places this provider in the 90th percentile of 486 psychiatric/mental health providers in Mississippi.
See all psychiatric/mental health providers in Mississippi →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 51 | $167,463 |
| VraylarCariprazine Hcl | 112 | $156,050 |
| AristadaAripiprazole Lauroxil | 40 | $111,774 |
| IngrezzaValbenazine Tosylate | 13 | $101,695 |
| Abilify MaintenaAripiprazole | 23 | $62,660 |
| TrintellixVortioxetine Hydrobromide | 31 | $17,954 |
| Paliperidone ErPaliperidone | 52 | $5,212 |
| Adderall XrDextroamphetamine/Amphetamine | 14 | $3,017 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 101 | $2,359 |
| Hydroxyzine Pamoate | 163 | $2,071 |
| Trazodone Hcl | 245 | $1,530 |
| Lurasidone Hcl | 45 | $1,368 |
| Divalproex Sodium | 57 | $1,155 |
| Divalproex Sodium ErDivalproex Sodium | 45 | $1,123 |
| Aripiprazole | 84 | $1,088 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $508 | $167,46351 claims |
| AbbVieVraylar | $1,763 | $156,050112 claims |
| Alkermes, Inc.Aristada | $402 | $111,77440 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $312 | $101,69513 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $142 | $62,66023 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $29 | $17,95431 claims |
| Teva Pharmaceuticals USA, Inc.Loxapine | $209 | $32412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 486 psychiatric/mental health providers in Mississippi.
Other psychiatric/mental health in Gulfport
- Desiree NormanGulfport$10K
- Tangular BarnesGulfport$9K
- Anita HallGulfport$8K
- Belinda HoldenGulfport$7K
- Chantal SullivanGulfport$7K
- Kari WilliamsGulfport$4K
- Jo DrennanGulfport$4K
- Elizabeth GarrigaGulfport$4K
- Ashley KarelVicksburg$129K
- Amanda HamCorinth$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.